8-KThe WireRoutine
Shareholder Vote
Filed Jun 22, 2023 · 3y ago · Accession 0000950170-23-029447
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- 8-K
- Filing date
- Jun 22, 2023
- Report date
- Jun 22, 2023
- Document
- acrv-20230622.htm
- Size
- 228 KB